1-3 of 3
Frederick Rickles, MD
Close
Sort by
Journal Articles

Pharmacologic Thromboprophylaxis Is Frequently Prescribed In Hospitalized Cancer Patients At Academic Medical Centers: A Prospective, Cross-Sectional, Multi-Center Study

Adam A. Rojan, MD, Nadia Q. Rehman, MD, Renee E. Funches, MD, Federico Campigotto, MS, Jonathan Webster, MD, Gregory C. Connolly, MD, Anita Aggarwal, DO, PhD, Dalia Mobarek, MD, MSc, Donna S. Neuberg, ScD, Ted Wun, MD, Frederick Rickles, MD, FACP, Michael B. Streiff, MD, Alok A. Khorana, MD, Jeffrey I. Zwicker, MD
Journal: Blood
Blood (2013) 122 (21): 2374.
https://doi.org/10.1182/blood.V122.21.2374.2374
Published: 2013
Journal Articles

Effects Of Dalteparin On The Heparanase/Syndecan-1 Axis In a Randomized Phase 2 Clinical Trial Of Patients With Treatment-Naive Multiple Myeloma

Sikander Ailawadhi, M.D., Howard A Liebman, MD, Susan Groshen, PhD, Denice D. Tsao-Wei, PhD, Leanne Rochanda, MS, Ibrahim Aldoss, MD, Casey O'Connell, MD, Teresa Wang, Christine Duran, Frederick Rickles, MD, FACP
Journal: Blood
Blood (2013) 122 (21): 5350.
https://doi.org/10.1182/blood.V122.21.5350.5350
Published: 2013
Journal Articles

Modulation of Cancer Cell-Associated Procoagulant Activity (PCA) by a Novel, Small Molecule, Orally Active Inhibitor of Oxidative Stress Pathways

Shaymaa S. Mousa, MD, Ghanshyam Patil, PhD, Lawrence Lansing, MD, Emmy Dier, MS, Theresa Kannanayakal, PhD, Frederick Rickles, MD, Shaker S Mousa, Ph.D., MBA, FACC, FACB
Journal: Blood
Blood (2008) 112 (11): 2666.
https://doi.org/10.1182/blood.V112.11.2666.2666
Published: 2008